Who We Are
Biologics by McKesson specialty pharmacy is a leader in creating truly exceptional patient experiences by simplifying connections for providers and delivering personalized care for every patient who we have the honor of serving.
We Focus on Our Patients
At Biologics specialty pharmacy, we focus on why we do what we do: our patients and the partners we work with. We specialize in cancer and rare disease areas. Our goals are to simplify access to therapies and deliver personalized clinical care that helps patients understand how to take their medication, manage side effects and achieve the best-possible outcomes. We also provide benefits investigation, assist with prior authorizations and help patients find financial aid so they can afford their treatment.
Setting the Standard
With over 25 years’ experience caring for patients with cancer and other complex and rare diseases, Biologics has a strong foundation of clinical care with our multidisciplinary care team, and we’ve built on that approach by layering in partnerships, programs and technology that allow us to further elevate the way we care for our patients and the access we can provide them.
What can we help you with today?
For Patients
Quick delivery, financial aid, side-effect management and adherence support.
For Providers
Fast time to first fill, customized solutions and exceptional patient care.
For Biopharma
Fast time to first fill, provider engagement and patient adherence.
For Payers
Cost management, industry-leading access and clinical care.
Biologics by McKesson News
RETEVMO (selpercatinib), FDA-Approved for Treatment of RET-driven Lung and Thyroid Cancers, Available at Biologics by McKesson
CARY, N.C., June 1—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Eli Lilly and Company as a specialty...
Pemazyre™ (pemigatinib) Available Exclusively at Biologics by McKesson
CARY, N.C., May 27, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, will be the exclusive specialty pharmacy provider for...
TRODELVY (sacituzumab govitecan-hziy), FDA Approved for Treatment of Metastatic Triple-negative Breast Cancer, Available Only at Biologics by McKesson
CARY, N.C., May 8, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Immunomedics, Inc. as a specialty pharmacy...
